The Outbreak of COVID-19 Pandemic Has Disrupted Growth for Rare Neurodegenerative Disease Treatment Market, Fact.MR Study
The new report on the Rare Neurodegenerative Disease Treatment market provides estimations of the size of the global market and share and size of key regional markets during the historical period of 2015 – 2019. The global rare neurodegenerative disease treatment market is projected to witness steady growth at a CAGR of 5%, reaching a valuation of over US$ 116 billion by 2030.The business intelligence study offers readers a granular assessment of key growth dynamics, promising avenues, and the competitive...
View full press release